Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-19-013904
Date:2019-02-24
Issuer: OVID THERAPEUTICS INC. (OVID)
Original Submission Date:

Reporting Person:

DURING MATTHEW
C/O OVID THERAPEUTICS INC.
1460 BROADWAY, SUITE 15044 NEW YORK, NY 10036

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
EMPLOYEE STOCK OPTION (RIGHT TO BUY) 1.89 2019-02-24 deemed execution date A 70,000 (a) 2029-02-23 common stock 70,000 $1.89 70,000 direct
Footnotes
IDfootnote
f1 25% of the shares subject to the stock option will vest and become exercisable on february 24, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the reporting person's continued services through such date.
WhaleWisdom Logo

Elevate your investments